Search research articles
Contact Us
Filters
Showing results (161-170 of 186) with videos related to
Page
of 19
Sort By:
The Lancet. Respiratory Medicine
|
May 8, 2021
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
Xiaojun Wu, Xiaofan Liu, Yilu Zhou, et al.
Molecular Cancer
|
November 8, 2015
MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α
Peng Yang, Fang Ni, Rui-Qing Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy
Mingming Zhang, Linghui Zhou, Houli Zhao, et al.
Cardiovascular and Interventional Radiology
|
September 23, 2020
Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study
Lei Zhang, Jun-Hui Sun, Zhong-Heng Hou, et al.
Frontiers in Oncology
|
August 28, 2020
Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Xiang-Pan Meng, Yuan-Cheng Wang, Shenghong Ju, et al.
Frontiers in Oncology
|
January 4, 2021
Prognostic Performance of Albumin-Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
Bin-Yan Zhong, Zhi-Ping Yan, Jun-Hui Sun, et al.
Bone Research
|
October 26, 2022
Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss
Chen Kan, Jiazhao Yang, Haitao Fan, et al.
Liver Cancer
|
April 2, 2026
Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study
Nan Jiang, Wen Zhang, Zhenwei Peng, et al.
BMC Infectious Diseases
|
September 27, 2023
Impact of non-pharmaceutical interventions during COVID-19 on future influenza trends in Mainland China
Xiaofan Liu, Ying Peng, Zhe Chen, et al.
Hepatobiliary Surgery and Nutrition
|
June 11, 2026
Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluation
Bin-Yan Zhong, Zhongzhi Jia, Ho-Young Song, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 186) with videos related to
Sort By:
Page
of 19
The Lancet. Respiratory Medicine
|
May 8, 2021
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
Xiaojun Wu, Xiaofan Liu, Yilu Zhou, et al.
Molecular Cancer
|
November 8, 2015
MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α
Peng Yang, Fang Ni, Rui-Qing Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy
Mingming Zhang, Linghui Zhou, Houli Zhao, et al.
Cardiovascular and Interventional Radiology
|
September 23, 2020
Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study
Lei Zhang, Jun-Hui Sun, Zhong-Heng Hou, et al.
Frontiers in Oncology
|
August 28, 2020
Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Xiang-Pan Meng, Yuan-Cheng Wang, Shenghong Ju, et al.
Frontiers in Oncology
|
January 4, 2021
Prognostic Performance of Albumin-Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
Bin-Yan Zhong, Zhi-Ping Yan, Jun-Hui Sun, et al.
Bone Research
|
October 26, 2022
Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss
Chen Kan, Jiazhao Yang, Haitao Fan, et al.
Liver Cancer
|
April 2, 2026
Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study
Nan Jiang, Wen Zhang, Zhenwei Peng, et al.
BMC Infectious Diseases
|
September 27, 2023
Impact of non-pharmaceutical interventions during COVID-19 on future influenza trends in Mainland China
Xiaofan Liu, Ying Peng, Zhe Chen, et al.
Hepatobiliary Surgery and Nutrition
|
June 11, 2026
Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluation
Bin-Yan Zhong, Zhongzhi Jia, Ho-Young Song, et al.
Page
of 19